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Abstract
The supernumerary chromosome 21 in Down syndrome differentially affects the methyla-
tion statuses at CpG dinucleotide sites and creates genome-wide transcriptional dysregula-
tion of parental alleles, ultimately causing diverse pathologies. At present, it is unknown
whether those effects are dependent or independent of the parental origin of the nondis-
joined chromosome 21. Linkage analysis is a standard method for the determination of the
parental origin of this aneuploidy, although it is inadequate in cases with deficiency of sam-
ples from the progenitors. Here, we assessed the reliability of the epigenetic 5mCpG
imprints resulting in the maternally (oocyte)-derived allele methylation at a differentially
methylated region (DMR) of the candidate imprintedWRB gene for asserting the parental
origin of chromosome 21. We developed a methylation-sensitive restriction enzyme-specific
PCR assay, based on theWRB DMR, across single nucleotide polymorphisms (SNPs) to
examine the methylation statuses in the parental alleles. In genomic DNA from blood cells
of either disomic or trisomic subjects, the maternal alleles were consistently methylated,
while the paternal alleles were unmethylated. However, the supernumerary chromosome
21 did alter the methylation patterns at the RUNX1 (chromosome 21) and TMEM131 (chro-
mosome 2) CpG sites in a parent-of-origin-independent manner. To evaluate the 5mCpG
imprints, we conducted a computational comparative epigenomic analysis of transcriptome
RNA sequencing (RNA-Seq) and histone modification expression patterns. We found allele
fractions consistent with the transcriptional biallelic expression ofWRB and ten neighboring
genes, despite the similarities in the confluence of both a 17-histone modification activation
backbone module and a 5-histone modification repressive module between theWRB DMR
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and the DMRs of six imprinted genes. We concluded that the maternally inherited 5mCpG
imprints at theWRB DMR are uncoupled from the parental allele expression ofWRB and
ten neighboring genes in several tissues and that trisomy 21 alters DNA methylation in par-
ent-of-origin-dependent and -independent manners.
Introduction
Trisomy 21 (Down syndrome) is the most common autosomal aneuploidy that is compatible
with life (average rate of 1/400-800 live births; average life expectancy of 55 years) [1]. The
supernumerary chromosome 21 results from meiotic nondisjunction errors in approximately
90–95% of cases during oogenesis [2, 3]. Thus, most individuals with Down syndrome inherit
two maternal complete and free copies of chromosome 21. Advanced maternal age increases
the risk of pregnancy with trisomy 21 [4], while the evidence for an association with paternal
age is inconsistent [5–8]. Therefore, the extremely skewed disparity observed between the
maternal and paternal meiotic errors at the origin of chromosome 21 nondisjunction is mainly
explained by the effect of advanced maternal age.
Although individuals with Down syndrome share phenotypically distinctive traits including
clinical manifestations of atypical and segmental accelerated aging [9], the syndrome exhibits a
large variety of physical stigmata that are unevenly represented among probands. Some of the
defects may constitute severe pathologies (i.e., cognitive dysfunction, acute lymphoblastic leu-
kemia, congenital heart disease, premature aging and Alzheimer disease-like neuropathology).
Despite the considerable number of clinical studies on the intellectual and physical disabilities
associated with trisomy 21, and owing to the small proportion of paternally inherited cases,
there is still no conclusive information regarding whether parent-of-origin (maternal versus
paternal) genetic factors contribute differentially to the observed phenotypic variation. For
example, in one study [10], no significant difference was found in the distribution of pheno-
typic clinical findings between Down syndrome patients with maternal (n = 150) and paternal
(n = 8) origin of the nondisjunction errors. In another study [11], congenital heart defects,
high arched palate, and short fingers occurred less frequently in cases with a paternally-derived
extra chromosome 21 (n = 8) than in cases with a maternally-derived extra chromosome 21
(n = 28). The main caveats in those reports are the use of a limited number of polymorphic
markers in the first study mentioned and the use of nucleolar organizer region heteromor-
phisms in the second study mentioned for the conclusive determination of the paternal origin
of the nondisjunction errors.
Considering the scenario of genomic imprinting on chromosome 21 [12], the parental ori-
gin of the supernumerary chromosome 21 will contribute differentially to the development of
some defects in a parent-dependent manner in Down syndrome. Notably, the uncommon con-
dition of a normal phenotype with maternal [13–15] or paternal [16, 17] uniparental disomy
(UPD) of chromosome 21 does not rule out the possibility of genomic imprinting of non-
essential genes. In fact, UPD involving chromosomes containing imprinted genes does not nec-
essarily reveal an imprinted pathological disorder with clinical consequences [18]. Importantly,
the extra copy of chromosome 21 causes a genome-wide [19, 20] domain pattern [20] of dysre-
gulation of gene expression, and it affects the DNAmethylation levels differentially at distinct
CpG dinucleotide sites [21, 22]. At present, it is also is unknown whether those effects are
dependent or independent of the parental origin of the nondisjoined chromosome 21.
The parental origin of the nondisjoined chromosome 21 can be established experimentally
in nuclear trios (mother, father, and proband) by linkage analysis using highly polymorphic
DNAmarkers (i.e., genotyping with short tandem repeats, STRs) [23]. Such expert analysis is
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difficult when DNA samples from the progenitors are unavailable. Here, we assessed the
dependability of reversible epigenetic molecular imprints resulting in germline-specific 5mCpG
for the discrimination of the parental origin of chromosome 21 nondisjunction. For that pur-
pose, we developed a PCR assay based on maternally derived allele methylation at a differen-
tially methylated region (DMR) located in the tryptophan-rich basic proteinWRB gene. Two
research groups recently identified the target maternal-of-origin 5mCpG imprints at theWRB
DMR using genome-wide methylation chip technology [24, 25]. The occurrence of a DMR in
theWRB gene warranted campaigning it as the first candidate maternally imprinted gene (i.e.,
paternally expressed) on the human chromosome 21. In contrast to the uniparental inheritance
pattern of allele expression determined by imprinting, one study reported alternate (i.e., oppos-
ing) monoallelic expression of the maternal or the paternalWRB alleles in different human
fetal tissues from the same embryo [25], a pattern consistent with random monoallelic expres-
sion, rather than with imprinting. Thus, we also reappraised the candidate imprinting status of
theWRB gene. We performed single-nucleotide polymorphism primer extension (SNuPE) at
informative 3´-UTR SNP variants in DNA from blood cells, and in human embryonic stem
cell lines (hESCs). Furthermore, we conducted an integrative and comparative epigenomic
computational analysis using transcriptome RNA sequencing (RNA-Seq) public repositories,
essentially adopting the frameworks recently described to explore enrichment-based sequenc-
ing data [26, 27].
Finally, we also evaluated the impact of the parental origin of the supernumerary chromo-
some 21 on the methylation statuses at CpG sites in the RUNX1 (chromosome 21) and
TMEM131 (chromosome 2) genes, the methylation levels of which are altered with trisomy 21
[21, 22, 28].
Materials and Methods
Ethics Statement
Peripheral blood samples from participating control and Down syndrome nuclear families
were collected with written informed consent. For infants and children with Down syndrome,
a surrogate consent procedure was used, whereby the next of kin or a legally authorized repre-
sentative consented in writing on the behalf of the participants. The subjects were included
from projects approved by the Ethics Committee of the Faculdade de Medicina de Campos,
Brazil (approval code FR-278769), the Faculdade de Medicina de São José do Rio Preto, Brazil
(HCRP 5810/2009) and the Universidade do Estado do Rio de Janeiro, Brazil (040/2005). The
main objectives of those projects were to develop molecular genetic tests for the determination
of the parental origin of the nondisjunction of human chromosome 21 and to screen for par-
ent-of-origin genetic risk factors for trisomy 21. This study was conducted according to the
principles expressed in the Declaration of Helsinki.
Subjects
We included 70 nuclear families (mother, father, and child) of either male or female index
cases with the full free trisomy 21 status established by conventional karyotyping (G band) in
at least 20 cells. We also included 20 families of children with no trisomy (controls). The aver-
age maternal age of index cases was 31.6 years (ranging from 16 to 44 years). After determining
the parental origin of the nondisjunction error for at least three informative STRs and selecting
for the informative SNPs in the target loci, 15 trios with a maternal origin (MT21), six with a
paternal origin (PT21) and 13 control trios (N21) met the criteria for the investigation of
parental-of-origin allele methylation and allele expression.
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Cell Lines
Cell pellets from the commercial, established human embryonic stem cell lines HUES 1, HUES
3, HUES 5, HUES 7, and HUES 15 were kindly provided by Christine L. Mummery, from the
Department of Anatomy and Embryology, Leiden University Medical Center, Leiden, The
Netherlands. General information regarding these cell lines is available at the NIH Human
Embryonic Stem Cell Registry (http://grants.nih.gov/stem_cells/registry/current.htm)
DNA and RNA Extraction
Human genomic DNA and total RNA from freshly drawn peripheral blood samples were
extracted using phenol-chloroform and ethanol precipitation [29] and TRIzol reagent (Invitro-
gen, Carlsbad, CA, USA), respectively, as previously described [30].
Determination of the Parental Origin of Chromosome 21 Nondisjunction
through Linkage Analysis
To select cases of trisomy 21 of either maternal or paternal origin of the nondisjunction error,
we performed linkage analysis by quantitative fluorescence PCR genotyping nuclear trios at
highly polymorphic STRs using fluorochrome-labeled primers and separating the amplimers
by high-resolution capillary electrophoresis. The physical locations and primer sequences are
shown in S1 Table. We determined the parental origin of the extra copy of chromosome 21 by
comparing the genotype of the index case with the parental genotypes at the informative STR
loci. We identified the parental alleles according to the following possible scenarios of allele seg-
regation: index case presenting with a triallelic pattern exhibiting allele ratios of approximately
1:1:1 or a biallelic pattern exhibiting a consistent allele ratio of 2:1. The observed genotypes are
shown in S2 Table.
Assessment of Heritable Epigenetic Methylation Imprints
To infer the methylation status at a given CpG island (CGI), we developed CGI-specific meth-
ylation-sensitive restriction enzyme-based PCR triplex assays (MSRE-PCR). In one tube reac-
tion, each assay amplifies the target CGI and two other genomic regions as a control for the
efficiency of the restriction enzyme digestion and to normalize the estimate ratios of the restric-
tion enzyme-resistant 5mCpG sites. Allele-specific methylation was determined by interrogat-
ing informative SNPs neighboring the target CGIs. Information regarding the physical location
of the selected target CGIs, 5mCpG-sensitive restriction enzymes, SNPs and primer sequences
used in the assays is included in S1 Table. Because of the potential diagnostic value of theWRB
DMR (CGI-2) for the discrimination of the parental origin of nondisjunction of the supernu-
merary chromosome 21, we describe its specific MSRE-PCR assay here. On untreated gDNA,
the assay generates three FAM-labeled amplimers of different lengths. On HhaI treated gDNA,
the combined pattern of the amplimers is used to determine one of three possible statuses of
methylation: hypomethylated, hemimethylated or hypermethylated. The genomic amplimers
are: (1) TheWRB DMR target region (observed amplicon size: 254 bp), encompassing the rec-
ognition sites for HhaI, and the rs2299739 and rs2244352 SNPs (S1 Table). (2) The known
unmethylated ESCO2 core promoter CGI (observed amplicon size ranging 248 to 250 bp),
encompassing many HhaI recognition sites. The ESCO2 core promoter CGI was originally fea-
tured as a query target in the SALSAMS-MLPA ME030 probemix commercial kit (MRC Hol-
land). This genomic amplimer provides information regarding the efficiency of the restriction
enzyme reaction. (3) A region (observed amplicon size ranging 269 to 271 bp) genetically
linked to theWRB DMR but lacking HhaI recognition sites. This amplimer serves as a
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normalization reference. Parental allele methylation statuses at theWRB DMR were assessed
by interrogating neighboring SNPs using a non-fluorescent uniplex version of the MSRE-PCR.
Next, we carried out SNuPE assays to genotype the methylated alleles, refractory to digestion
with the restriction enzyme, using SNaPshot technology (Thermo Fisher Scientific, Waltham,
MA, USA). To validate the parental allele-specific methylation statuses, we used theMcrBC
restriction endonuclease that acts upon DNA containing methylcytosine on one or both
strands [31]. We used the same experimental design to profile the methylation statuses at
5mCpG-restriction enzyme sensitive sites located at theWRB CGI-1 and CGI-3. To evaluate
the impact of the parental origin of the extra copy of chromosome 21 in the methylation of
CpG sites at the RUNX1 and TMEM131 genes, we developed gene-specific methylation-sensi-
tive restriction enzyme MSRE-PCR assays (S1 Table).
We calculated the ratio of restriction enzyme-resistant 5mCpG sites at the queried CGIs
using the following equation:
%Meth ¼
CðC  fABÞ
CðC ðfABÞþDþðD  fABÞ
h i
DþðD  fABÞ
CðC  fABÞþDþðD  fABÞ
h i
8<
:
9=
; 100; fAB ¼
A 100
A þ B
 
 50
 
 0:02
where, C is the value of the area under the peak (AUP) of the queried CGI amplimer from the
restriction enzyme digested DNA sample; D is the AUP of the negative amplimer from the
restriction enzyme digested DNA sample, and fAB is the correction factor that accounts for the
lack of symmetry and imbalance observed between the AUP for the queried GCI amplimer (A)
and the negative amplimer (B) obtained from the undigested DNA sample.
An Androgenetic Reference Sample of Methylation Statuses in Male
Germline Derivatives
The homogenous androgenetic nature of the hydatidiform mole was determined by comparing
the genotypes (S3 Table) of the two samples of the same specimen with that of a peripheral
blood sample from the donor by quantitative fluorescence PCR using the AmpFlSTR Identifiler
system (Thermo Fisher Scientific, Waltham, MA, USA).
Assessment of Transcriptional Allele Expression
To discriminate between the possible biallelic and the monoallelic patterns of transcriptional
expression of theWRB gene, we interrogated 3´-UTR SNPs in cDNAs obtained from heterozy-
gous blood donors and hESCs using SNaPshot technology. For comparison, we genotyped
SNPs at two paternally imprinted reference genes: H19 [32] and ATP10A [33]. Primer
sequences are shown in S1 Table.
High-Resolution Capillary Electrophoresis for Separation of
Fluorochrome-Labeled Amplimers
Amplimers were analyzed on an automated laser fluorescent ABI PRISM 310 Genetic Analyzer
(Thermo Fisher Scientific, Waltham, MA, USA). The electropherograms were generated using
the dedicated GeneScan1 Analysis and Genotyper1 software version 3.7 packages and Gene-
Mapper1 ID version 3.2 (Applied Biosystems1 from Thermo Fisher Scientific, Waltham,
MA, USA).
DNAMethylation and Trisomy 21 Parent-of-Origin
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The Methylation Statuses at theWRBCpG Islands in Methylome Public
Datasets
To examine the methylation patterns at the CGI mapped to the referenceWRB locus, we per-
formed an integrative and comparative epigenomic computational analysis by viewing the
Smith Lab Public DNA methylation track hub [34] and the 111 distinct epigenomes from the
Roadmap Consortium [35] at the UCSC Genome Browser [36, 37]. The Smith Lab Public
DNAmethylation track hub comprises a pre-loaded set of 183 analyzed human methylomes
from bisulfite sequencing experiments from brain [38–40], hESCs [41], induced pluripotent
stem cells (iPSCs) [42] and blood cells [43–45]. The rates of 5mCpG along the chromosome 21
in human oocytes [46] were displayed as a custom track in the UCSC Genome Browser. We
graphically displayed the predicted promoters and CTCF and POL2 binding sites at the UCSC
interface using the Ensembl Regulatory Build and Transcription Factor Binding track resource
[47].
Identification of DNA Motifs Mapping at theWRB DMR
To search for cis-acting motifs that may be implicated in the differential epigenetic statuses of
theWRB DMR, we queried published libraries of DNA-binding proteins with the FASTA ref-
erence sequence for theWRB DMR using online search DNA motif programs [48, 49]. We also
used Tandem Repeat Finder [50] to scan theWRB DMR DNA reference sequence for the pres-
ence of ungapped (regular, fixed-length patterns) DNA repeat elements. The downstream anal-
ysis for the identified array is based on the rationale that cis elements constitute platforms on
which the interactions with site-specific DNA-binding factors are built to establish and main-
tain epigenomic modifications [51]. To investigate whether the identified DNAmotifs corre-
spond to transcription factor binding sites, we compared the DNAmotifs against a database of
known motifs using the TOMTOM tool [52], which ranks each suitable match to the query
and displays motif web logos. To address whether the motifs found in theWRB DMR are pres-
ent in other loci, we searched the entire reference genome sequence using the FIMO tool [53]
from the MEME program suite [48] available online at http://meme-suite.org/. The conserva-
tion of the array of DNA motifs was investigated by lifting over the coordinates in the reference
genomes of vertebrates using the LiftOver tool from the UCSC Genome Browser [36] and sub-
mitting the lifted FASTA sequences to the motifs analysis. The coordinates of the tandem
repeat motif array were then graphically displayed in the UCSC Genome Browser [36, 37]
using the custom track tool.
Combinatorial Histone Modification Expression Signatures
We compared the common combinatorial histone modification expression patterns across the
DMRs in 29 known maternally and two paternally imprinted genes [46] with that in the candi-
date imprintedWRB gene by displaying the sequence features and the activating or repressive
histone marks in the UCSC genome browser using annotation and track hubs. As testable pre-
dictions of the epigenetic status, we used the following two modification modules defined by
Wang and collaborators in human CD4+ T cells [54]. The 17-histone modification activation
backbone module: H2A.Z, H2BK5ac, H2BK12ac, H2BK20ac, H2BK120ac, H3K4ac,
H3K4me1, H3K4me2, H3K4me3, H3K9ac, H3K9me1, H3K18ac, H3K27ac, H3K36ac,
H4K5ac, H4K8ac, and H4K91ac. The 5-histone modification repressive module: H3K27me3,
H3K27me2, H3K9me3, H3K9me2, and H4K20me3.
DNAMethylation and Trisomy 21 Parent-of-Origin
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Reappraisal of the Candidate Maternally Imprinting Status of theWRB
Gene Using Secondary Analysis of Massive Parallel RNA Sequences
Wemeasured allelic imbalance at likely heterozygous loci that map within a 4-Mb chromo-
somal region centered at theWRB gene by querying RNA sequence read archive (SRA) public
data repositories. We included exon, 5´-UTR, 3´-UTR and ncRNA SNPs being 159 SNPs with
MAF> 0.1 (i.e., expected global heterozygosity rate of 0.18) as testable predictions and 4 SNPs
with MAF<0.05 as a control for monoallelic expression (S4 Table), mapping to within 35
genes and ncRNAs. As a reference, we used SNPs at the SNURF andH19 genes (S1 Table),
which are both imprinted in every human tissue tested so far [55]. The public databases are
available at NCBI Gene Expression Omnibus GEO (http://www.ncbi.nlm.nih.gov/geo/) [56],
EMBL-EBI ArrayExpress (https://www.ebi.ac.uk/arrayexpress/) [57] and the Human Protein
Atlas (http://www.proteinatlas.org/). We used the SRA nucleotide search expression online
tool from the NCBI Browser (http://trace.ncbi.nlm.nih.gov/Traces/sra/) to download FASTQ
filtered reads. The SRA Nucleotide Search Expression tool returns biological reads for an
RNA-Seq spot containing a sequence substring encompassing a given SNP. Each sequence sub-
string was limited to 29 characters in 4NA alphabet including the International Union of Pure
and Applied Chemistry (IUPAC) substitution codes for the query SNPs (S1 and S4 Tables).
We used IUPAC genomic reference to correct for reference allele preference during alignment
[58]. We restricted the analysis to two series of experiments. The first included 1,012 human
RNA-Seq sample runs (S5 Table) selected from the 4,978 unsorted accessions recently analyzed
by Deelen et al. (2015) [59]. The second included 212 SRA accessions from public repositories
and sorted into 15 primary tissue sources (S6 Table) by their reported Biosample and Biopro-
ject unicity (i.e., one sample, not a mixture, from a single donor). We quantified the allele frac-
tions only in runs that yielded a depth of at least 80 reads, with a quality of base calls> Q30,
increasing the variant confidence detection to a probability of correct SNP call of 0.999 pro-
vided a read depth (coverage) of 40 for a theoretical heterozygous position [60]. We categorized
the patterns of allele expression as monoallelic, biallelic or biallelic imbalance. The criteria
were: monoallelic if the allele fractions were< 0.15 or> 0.85; biallelic if the allele fractions ran-
ged from 0.35 to 0.65; and biallelic imbalance if the allele fractions ranged from> 0.15 to
<0.35 or> 0.65 to<0.85. We used a chi-square test to evaluate whether the allele-specific read
counts deviated from the expected proportions (50/50) [58]. To map FASTQ formatted, fil-
tered spot RNA raw sequence data to the hg19 reference sequence we used a flexible workflow
created with the web-based Galaxy tool suite (https://usegalaxy.org/) [61]. The workflow incor-
porates the use of the following software tools: FastQC (read quality control check) [62],
FASTQ Groomer, Filter by quality (Phred score quality cut-off: 25; minimum percentage: 90),
removal of sequencing artifacts, Bowtie2, BWA, BAM-to-SAM, Filter SAM or BAM, output
SAM or BAM (reads with maximum 01 variant or reads with no variant), and FreeBayes
(Bayesian genetic variant detector). We visualized the filtered and aligned reads using the
UCSC graphical interface.
Results
The Methylation Statuses at theWRBCpG Islands
TheWRB reference sequence locus contains five annotated CpG islands, CGI-1, CGI-2, CGI-3,
CGI-4, and CGI-5 comprising 64, 27, 19, 17 and 18 CpG dinucleotide sites, respectively (Fig 1).
CGI-1 encompasses the 5´-UTR and exon 1 of the ENST00000333781.8 referenceWRB tran-
script variant 1 (long variant), and maps to a predicted promoter region. In public methylome
databases, CGI-1 is essentially unmethylated in gametes and in somatic and embryonic cells
DNAMethylation and Trisomy 21 Parent-of-Origin
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and tissues (Fig 1). CGI-2 maps to a second predicted promoter region, located upstream of
the TSS of the ENST00000380708.4 referenceWRB transcript variant 2 (short variant) (Fig 1).
CGI-2 is located within the differentially methylated region (DMR) reported by Court and col-
laborators [24] and Docherty and collaborators [25] for whichWRB was classified as a candi-
date maternally imprinted gene (i.e., paternal-origin allele expressed). CGI-2 is differentially
methylated in oocytes versus sperm [46], partially methylated in adult somatic tissues, and
hypermethylated in embryonic cells and tissues (Fig 1). CGI-3 is differentially methylated in
female and male gametes, essentially unmethylated in adult cells and tissues, and hypomethy-
lated in embryonic stem cells (Fig 1). CGI-4 is hypermethylated in gametes, in all somatic cells,
and in tissues (Fig 1). CGI-5 is differentially methylated in the gametes and is ubiquitously
hypermethylated in somatic cells and tissues (Fig 1).
Using target-specific MSRE-PCR assays, we experimentally replicated the above methyla-
tion statuses at theWRB CGI-2 (Fig 2A), CGI-1 (Fig 2B), and CGI-3 (Fig 2C) in genomic DNA
from disomic individuals. The overall average ratio of restriction enzyme-resistant 5mCpG
sites at theWRB CGI-2 was 47.4% in disomic blood cells from adult donors (S7 Table). In
hESCs, the overall average ratio of 5mCpG sites was 82.1% (S7 Table). In contrast, the assay
Fig 1. Themethylation statuses at the CpG islands of theWRB gene in methylome public datasets. Chromosomal, physical map positions and
sequence features of the referenceWRB gene locus showing the methylation profiles across the region, with an emphasis on the five annotated CpG islands
(CGI-1 to CGI-5). The features depicted are from custom and public tracks for (from top to bottom) the exon organization of the principal
(ENST00000333781.8) and alternative (ENST00000380708.4) spliceWRB isoforms (variants 1 and 2 in dark blue) (UCSCGenes [36]), the species-
conserved principal transcript (ENST00000333781 in pink) (APPRIS [75]), the Ensembl Regulatory Build CTCF and POL2 activity and predicted promoters
[76], CpG islands, CpG sites, and regulation and methylome studies indicated in the Materials and Methods section. The CGI-2 is located in the differentially
methylated region (DMR) reported by Court and collaborators [24] and Docherty and collaborators [25] (depicted in red in the custom track named Court/
Docherty DMR), from whichWRB was classified originally as a novel candidate, maternally imprinted gene (i.e., paternal-origin allele expressed). The
custom tracks containing the sperm and oocyte DNAmethylation signals correspond to the supplementary data reported by Okae et al. [46]. Screenshot
generated using the UCSCGenome Browser hg19 (http://genome.ucsc.edu).
doi:10.1371/journal.pone.0154108.g001
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revealed a consistent unmethylated pattern of CpG sites at theWRB CGI-1 (Fig 2B) and CGI-3
(Fig 2C).
The allele-specific methylation at theWRB CGI-2 DMR was assessed experimentally across
the neighboring rs2244352 SNP in genomic DNA from peripheral blood cells of disomic het-
erozygous subjects. The maternal alleles were consistently methylated (i.e., refractory to diges-
tion withHhaI and susceptible to digestion withMcrBC) while the paternal alleles were
unmethylated (i.e., susceptible to digestion withHhaI and refractory to digestion withMcrBC)
(Fig 3). Thus, the underlying genetic basis for the hemimethylated profiles observed at the
WRB CGI-2 DMR is unequivocally due to the inheritance of specific maternal-allele 5mCpG
imprints.
Discrimination of the Parental Origin of Chromosome 21 Nondisjunction
Using Heritable 5mCpG Imprints at the WRB CGI-2 DMR
We assessed the dependability of the known heritable epigenetic methylation [24, 25] resulting
in maternal allele methylation imprints at theWRB CGI-2 DMR to ascertain the parental ori-
gin of chromosome 21 nondisjunctional events in trisomy 21 probands. For these experiments,
the parental origin of the nondisjunctional events was unambiguously established by linkage
analysis in nuclear families using highly polymorphic STRs. The genotypes and the segregating
alleles are shown in S2 Table.
The ratios of restriction enzyme-resistant 5mCpG sites at theWRB CGI-2 DMR were signif-
icantly different between the MT21 probands (average ratio of 68.4%) and the PT21 probands
(average ratio of 33.5%) (Fig 4 and S7 Table). As it follows from the inheritance of maternal-
allele derived 5mCpG imprints, theWRB CGI-2 was unmethylated in DNA from a complete
androgenetic mole (Figs 4 and 5A). In hESCs (Figs 4 and 5B, and S7 Table), theWRB CGI-2
was hypermethylated, indicating the loss of the imprinted pattern of 5mCpG marks at this
developmental stage.
Parent-of-Origin-Independent Altered Methylation Effects Due to the
Extra Copy of Chromosome 21
Because the supernumerary copy of chromosome 21 differentially affects the methylation sta-
tuses at distinct loci in the genome [21, 22], we tested whether the levels of methylation at loci
in either cis- or trans-configuration with regards to theWRB CGI-2 DMR change in a parent-
of-origin-dependent fashion. Using the MSRE-PCR approach, we assessed the methylation sta-
tuses at CpG sites within the RUNX1 (cis) and TMEM131 (trans) genes that are differentially
epigenetically perturbed in trisomic samples versus disomic samples [21, 22, 28]. Compared
with disomic individuals, in trisomic subjects there is a gain of methylation at RUNX1 and a
loss of methylation at TMEM131. We replicated the reported perturbation effects of the extra
copy of chromosome 21 on the methylation patterns at these loci. Importantly, and in contrast
to the situation at theWRB CGI-2 DMR, the epigenetic perturbations observed at the RUNX1
Fig 2. Experimental validation of the 5mCpG statuses at theWRBCGIs. (A) A consistent hemimethylated pattern at theWRBCGI-2 revealed in a
representative control disomic DNA sample (blood) using the HhaImethylation-sensitive restriction enzyme-based PCR triplex assay developed in this study.
Electropherograms of the amplimers generated from either undigested genomic DNA (upper panel) or DNA digested withHhaI (lower panel) genotyped via
quantitative fluorescent PCR. The positive amplimer refers to a locus in the ESCO2 gene with constitutively hypomethylated CpG dinucleotides at the target
restriction enzyme sites (100% susceptible to HhaI digestion). The negative amplimer refers to aWRB region that lacksHhaI sites, and is, therefore,
refractory to enzymatic digestion. The numbers in the upper boxes correspond to the amplimer lengths in base pairs while those in the lower boxes refer to
the areas under the peak of the amplimer. In this representative DNA sample, the ratio of 5mCpG sites at theWRB CGI-2 was 50.6%. In contrast, the assay
revealed a consistent unmethylated pattern of CpG sites at theWRBCGI-1 (B) andWRBCGI-3 (C).
doi:10.1371/journal.pone.0154108.g002
DNAMethylation and Trisomy 21 Parent-of-Origin
PLOS ONE | DOI:10.1371/journal.pone.0154108 April 21, 2016 10 / 26
DNAMethylation and Trisomy 21 Parent-of-Origin
PLOS ONE | DOI:10.1371/journal.pone.0154108 April 21, 2016 11 / 26
(Fig 6A) and TMEM131 (Fig 6B) genes were independent of the parental origin of the supernu-
merary chromosome 21.
The Maternal 5mCpG Imprints at theWRBCGI-2 DMR Do Not Dictate a
Paternal Monoallelic Expression
To assess whether the maternal allele-specific methylation pattern observed at the intragenic
WRB CGI-2 DMR is indicative of functional gene regulation differences in the form of
Fig 3. Maternal-of-origin-dependent imprintedmethylationmarks at theWRBCGI-2 DMR. 5mCpG-
sensitive restriction endonuclease sites at theWRBCGI-2 DMR are differentially methylated on the maternal
allele versus the paternal allele in a manner consistent with imprinting. Electropherograms of the genotype
profiles in a control nuclear family, informative for the rs2244352 (C>A) SNP neighboring theWRBCGI-2
DMR. In the child, the maternal-derived C allele is 100% resistant to HhaI digestion (fully methylated),
whereas the paternal-derived A allele is 100% susceptible to HhaI digestion (i.e., unmethylated). The parental
allele-specific methylation statuses were validated using theMcrBC restriction endonuclease that cleaves
methylated DNA and, therefore, the unmethylated paternal allele, but not the maternally methylated allele,
remains undigested.
doi:10.1371/journal.pone.0154108.g003
Fig 4. Thematernal (oocyte)-derived allele methylation at theWRBCGI-2 distinguishes the parental origin of chromosome 21 nondisjunction
events in Down syndrome probands. The proportion of HhaI-resistant 5mCpG sites at theWRB CGI-2 DMR in trisomic samples with a maternal origin
(MT21) of the nondisjoined chromosome 21 is consistently and statistically higher than in trisomic samples with a paternally (PT21) derived extra copy of
chromosome 21. In genomic DNA from an androgenetic hydatidiform mole (ACHM), theWRBCGI-2 is unmethylated, whereas it is hypermethylated in
hESCs. In control disomic samples (N21) the locus is partially methylated, consistent with a hemimethylated state. All differences were statistically
significant.
doi:10.1371/journal.pone.0154108.g004
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genomic imprinting, we qualitatively tested for allele-specific gene RNA expression by interro-
gating 3´-UTR SNP variants in cDNAs of RNA from blood samples and hESCs. We noted that
both the maternal and paternal alleles were expressed in heterozygous samples independently
of the methylation statuses observed at theWRB CGI-2 DMR (Fig 7). In hESCs, in which the
WRB CGI-2 DMR is hypermethylated, theWRB transcriptional expression profile was biallelic
(Fig 8).
Genomic imprinting can either completely silence one parental allele or significantly reduce
its expression. We queried RNA-Seq public archives using sequence substrings for each exon 1
Fig 5. 5mCpG statuses at theWRBCGI-2 DMR in a complete androgenetic mole and a human embryonic stem cell line. A consistent unmethylated
pattern of CpG sites at theWRBCGI-2 DMR revealed in a sample of an androgenetic complete hydatidiform mole (A) contrast with the hypermethylated
pattern observed in the representative HUES 3 embryonic cell line (B). Electropherograms of the amplimers (see details of the assay in Fig 2) generated from
either undigested DNA or HhaI-digested DNA. The numbers in the upper boxes correspond to the amplimer lengths in base pairs while those in the lower
boxes refer to the areas under the peak of the amplimer.
doi:10.1371/journal.pone.0154108.g005
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of the two majorWRB reference transcripts, variants 1 (ENST00000333781.8) and 2
(ENST00000380708.4). We found evidence of expression (> 80 reads) of theWRB transcript
variant 1 in RNA-Seq experiments in the brain, fallopian tube, liver, muscle, ovary, skin, and
testis samples (S8 Table). However, using a sequence substring specific for the exon 1 of the
WRB transcript variant 2, the number of reads filtered in each SRA accession from primary tis-
sues was consistently 16, thus impairing further analysis of this short transcript variant (S8
Table) according to our stringent criteria.
Because relevant genotypes are unfortunately lacking in the entire RNA-Seq datasets ana-
lyzed (i.e., samples are not DNA/RNA exome sequencing pairs), we next aimed to provide
RNA-Seq evidence for either monoallelic or biallelic expression queried with the rs1060180
and rs13230WRB 3´-UTR SNPs. These SNPs map to both the long and shortWRB transcript
variants. In the 1,012 unsorted RNA-Seq experiments, we found allele fractions consistent with
a biallelic pattern of expression (mean allele fraction ranging from 0.49 to 0.51) for both SNPs
in the brain, epidermal keratinocytes, fetal large and small intestine, large airway epithelial
cells, ovary, skin and testis samples (S9 Table). In the analysis of the RNA-Seq public databases
sorted by tissue, we also observed allele fractions consistent with biallelic expression across the
WRB 3´-UTR SNPs in brain, fallopian tube, thyroid, muscle, ovary, skin, and testis samples
(S10 Table). Altogether, we observed no suppression or expression bias effects on either allele
(i.e., the evidence against a maternally suppressed, imprinting effect) in ten biosamples (brain,
fallopian tube, fetal large and small intestine, large airway epithelial cells, thyroid muscle, epi-
dermal keratinocytes, ovary, skin, and testis). In contrast, for the known imprinted SNURF
gene (tested across the rs705 SNP in the brain, fallopian tube, liver, muscle, ovary, skin, and tes-
tis) both alleles were expressed monoallelically (i.e., passed the “flip test” required for genomic
imprinting) (S10 Table). Similarly, for the H19 rs217727 andH19 rs10840159 SNPs we
Fig 6. Parent-of-origin-independent methylation effects of the supernumerary chromosome 21 on both syntenic and non-syntenic genes. (A) A
statistically significant gain of methylation at CpG dinucleotide sites within the syntenic RUNX1 gene is observed in trisomic individuals compared with control
disomic samples (N21). The gain is independent of the maternal (MT21) or the paternal (PT21) origin of the nondisjunction event. (B) A statistically significant
loss of methylation at CpG dinucleotide sites within the non-syntenic TMEM131 gene is observed in trisomic individuals compared with control disomic
samples (N21). The loss is independent of the maternal (MT21) or the paternal (PT21) origin of the nondisjunction event.
doi:10.1371/journal.pone.0154108.g006
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observed monoallelic expression of both alleles in the fallopian tube, ovary, and testis (S10
Table).
Because some known DMRs are physically distant up to 2-Mb from the target imprinted
gene [24, 25], and therefore function as imprinted control regions (ICRs), we extended the
query to 162 SNPs (S4 Table), mapping within a 4-Mb chromosomal region centered at the
WRB gene. Most SNP substrings yielded< 20 reads and, therefore, were unsuitable for further
analysis according to the inclusion criteria. Importantly, in addition toWRB, we found SNPs
with> 80 reads yielding allele fractions that were consistent with the biallelic expression in 15
Fig 7. Thematernally derived, imprinted 5mCpGmarks at theWRBCGI-2 DMR do not dictate a paternal monoallelic expression in blood.Qualitative
SNuPE allele-specific profiling of theWRB 3´-UTR rs1060180, rs13230 and rs60490159 SNPs in a disomic, informative nuclear family (DNA). The assay
reveals a pattern consistent with biallelic transcriptional expression (cDNA) in the child, who is heterozygous for all three SNP variants.
doi:10.1371/journal.pone.0154108.g007
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biosamples in 10 genes: DYRK1A, KCNJ15, ETS2, PSMG1, BRWD1,HMGN1, LOC102724757,
LCA5L, SH3BGR, and BACE2 (Fig 9, and S10 and S11 Tables).
Common Combinatorial Patterns of Histone Acetylation and Methylation
Marks at the PredictedWRB Promoter Regions
We next intended to identify epigenetic histone marks around theWRB CGI-2 DMR that con-
flate traceable combinatorial patterns, which possibly regulate the expression patterns of the
WRB transcript variants 1 and 2. We conducted the comparative analysis of DMRs classified as
germline DMRs (gDMRs) [46] and associated with patterns of imprinted methylation or
expression. We found similarities in the confluence of both the 17-histone modification activa-
tion backbone module and the 5-histone modification repressive module at the CGIs mapping
to the long (ENST00000333781.8) and short (ENST00000380708.4) transcript variants of the
WRB gene and at the gDMRs of the BLCAP, GNAS, IGF2R, GRB10, and RB1 genes, which
were most striking with theMEST gDMR (Fig 10 and S1 Fig).
DNAMotifs at theWRB CGI-2 DMR
Based on a computational comparative analysis of genomic reference sequences, we observed
that the nucleotide sequence encompassing the CGI-2 is conserved among primates (Fig 11A).
We analyzed the region for the occurrence of arrays of cis elements (other than the CpG dinu-
cleotide sites) that may be specific to this DMR or common to known DMRs by searching for
sequence motifs as testable predictions of the differential epigenetic status. We found the DNA
repeat motif [AGGYGBYSYAGGACT] (Fig 11B). In humans, the motif occurs in a cluster of
seven tandem units. The motif repeat units are spaced at regular chromosomal intervals
Fig 8. Thematernally derived, imprinted 5mCpGmarks at theWRBCGI-2 DMR do not dictate a paternal monoallelic expression in a human
embryonic stem cell line. Allele-specific transcriptional profiling of theWRB 3´-UTR rs1060180 SNP in the informative hESC HUES 1 sample (DNA; upper
panel) reveals a pattern consistent with biallelic expression (cDNA; lower panel). In contrast, for the known paternally imprintedH19 and ATP10A genes, the
expression profiles for the informative rs2839702 and rs2076743 SNPs, respectively, are monoallelic.
doi:10.1371/journal.pone.0154108.g008
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through theWRB DMR (CGI-2), encompassing 388 bp (Fig 11C). We then searched the whole
genome reference sequence and were unable to find other loci containing the array that occurs
at theWRB CGI-2 DMR. The [AGGYGBYSYAGGACT] motif repeat unit has sequence simi-
larity (i.e., match overlap of thirteen nucleotides in the optimal alignment) to the putative mul-
timer SPDEF_DBD_2 DNA-binding specificity consensus site ([gtggTCCCGGATYAT]) of the
transcriptional factor SPDEF (HumanTF 1.0 DNA binding motif library) [49, 63]. The number
of [AGGYGBYSYAGGACT] DNA motif units has varied since its evolutionary occurrence in
marmosets (Fig 11C).
Discussion
In this multidisciplinary study, we used complementary experimental and computational
approaches to address the challenging biological questions of whether the extra copy of
Fig 9. The allele expression ofWRB and ten neighboring genes is uncoupled from the control of the maternally inherited 5mCpG imprints at the
WRBDMR. (A) UCSCGenome Browser screenshot of custom tracks for the chromosomal and physical map positions of (top to bottom) the 11 genes that
map within the 4-Mb chromosomal region centered at theWRB gene, for which evidence for biallelic transcriptional expression was unveiled in this study,
and the relative locations of the 162 SNPs queried in RNA-seq public repositories for the determination of allele expression fractions. (B) Density distribution
plot, by primary tissue, of the number of SRA accessions of RNA-seq experiments that yielded evidence consistent with biallelic expression. For each gene
column, the intensity of the green color of each cell is proportional to the indicated numbers of informative SRA experiments. For each gene, the number of
primary tissues with evidence is represented in the bottom row in blue scale.
doi:10.1371/journal.pone.0154108.g009
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chromosome 21 in Down syndrome affects the methylation patterns at distinct CpG dinucleo-
tide sites and whether the epigenetic alterations occur dependently or independently of the
parental origin of the nondisjoined chromosome 21.
Although prior studies had shown that the extra copy of chromosome 21 differentially
affects the DNA methylation levels at distinct CpG dinucleotide sites [21, 22], it was unknown
whether the effects are dependent (i.e., genomic imprinting) and/or independent of the paren-
tal origin of the nondisjoined chromosome 21. We showed these epigenetic effects on three
genes, two located on chromosome 21 (WRB and RUNX1) and one located on chromosome 2
(TMEM131).
We established that the supernumerary chromosome 21 altered the methylation patterns at
distinct CpG dinucleotide sites in the RUNX1 and TMEM131 genes in a parent-of-origin-inde-
pendent manner. From a genome-wide perspective, this finding suggests that the epigenetic
effect of the extra copy of chromosome 21 does not vary greatly with the parental origin of the
supernumerary copy of chromosome 21; however, the extra copy does affect the methylation
statuses of genes located on the same and other chromosomes.
We explored the differentially heritable epigenetic methylation imprints at theWRB CGI-2
DMR to develop a simple PCR assay based on the maternally imprinted 5mCpG marks to
ascertain the parental origin of chromosome 21 nondisjunctional events in Down syndrome
probands. The assay does not require bisulfite conversion and improves on the current linkage
Fig 10. Common combinatorial histonemodification expression patterns around theWRB CGI-2 DMRs.Graphical representation of the confluence of
activating and repressive epigenetics histone modification marks for the known imprintedMEST gene (A) and the candidate imprintedWRB gene (B). Shown
are the 17-histone modification activation backbone module and the 5-histone modification repressive module found in human CD4+ T cells [54]. Highlighted
in light blue is the DMR in each gene. Composite of screenshots of the dataset viewed at the UCSCGenome Browser hg18 (http://genome.ucsc.edu).
doi:10.1371/journal.pone.0154108.g010
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analysis approach by not requiring genomic DNA from the progenitors. This epigenetic feature
will be an asset when parental samples are unavailable as in the situation of cryopreserved
banked specimens. In addition to the notorious scarcity (incidence of approximately 5%) of the
nondisjunctional events of paternal origin, the dependability of their identification from DNA
available from the progenitors has precluded studies on phenotype-(epi)genotype correlations
for Down syndrome of patrilineal descent. TheWRB CGI-2 DMR-based assay will greatly
facilitate the identification of Down syndrome cases of paternal origin and the establishment of
representative cohorts for studies on the variation in phenotypic outcomes. The assay will also
be useful in the prenatal molecular diagnosis of the parental origin, without collecting parental
samples, in triploid pregnancies where only the conceptuses with two paternal sets have the
potential to cause maternal complications [64].
The initial evidence suggesting a functional link between the maternal-of-origin-specific
imprinted methylation at theWRB CGI-2 DMR and theWRBmonoallelic expression came
from the study by Docherty and collaborators [25]. By sequencing cDNA across the rs1060180
SNP, they observed alternate (i.e., maternal or paternal) monoallelic transcript expression in
skeletal muscle and aorta tissues and biallelic transcript expression in the spinal cord from the
same embryo. Unfortunately, that study did not conclusively establish whether the paternal
allele is unmethylated. Moreover, a distinctive feature of imprinted genes is the preference for
the full expression of one (and always the same) of the two parental alleles [65]. Importantly,
alternate monoallelic transcript expression occurs only between different genes regulated by
the same imprinting control region. For example, between the paternally expressed Peg13 non-
coding RNA and the maternally expressed Kcnk9 gene in the mouse brain [66], and between
the maternally expressedH19 and the paternally expressed Igf2 genes in mouse hematopoietic
stem and progenitor cells [67].
We evaluated the candidate imprinting status of theWRB gene. We showed that the mater-
nal heritable epigenetic 5mCpG imprints at a CGI-2 DMR were uncoupled to the predicted
monoallelic expression of the paternalWRB allele. We replicated this observation in twelve
biosamples (brain, blood, fallopian tube, fetal large and small intestine, hESCs, large airway
Fig 11. TheWRBCGI-2 DMR contains a primate-conserved cluster array of a DNAmotif. (A) Molecular phylogenetic relationship of eightWRBCGI-2
DNA primate reference sequences inferred using multiple sequence alignment by CLUSTALW. (B) Sequence logo of the primate-conserved
[AGGYGBYSYAGGACT] DNA repeat unit that occurs at theWRBCGI-2. (C) Physical map of the primate-conserved [AGGYGBYSYAGGACT] DNA repeat
unit array.
doi:10.1371/journal.pone.0154108.g011
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epithelial cells, thyroid, muscle, epidermal keratinocytes, ovary, skin, and testis). These results
are in agreement with recently reported findings from three genome-wide scale analyses of
public RNA-Seq data [26, 59, 68]. These studies reported mean allele fractions showing either
non-significant deviation (mean value = 0.504) [26, 59] or significant deviation (average value
ranging from 0.553 to 0.803) [26, 68] for theWRB 3´-UTR rs1060180 and rs13230 SNPs. Fur-
thermore, we provide evidence from 15 tissue repositories of allele rates that are consistent
with the biallelic transcript expression of 10 genes that map to within 2-Mb around theWRB
gene. Thus, the allele transcript expression of 11 genes in at least one primary human tissue
tested is uncoupled from the control of maternally inherited imprints at theWRB DMR.
Steyaert and collaborators [26] used a SNP-guided analytical framework to identify monoal-
lelic DNAmethylation events from enrichment-based sequencing data. In theWRB gene, they
functionally annotated the locus comprising the SNP rs2299739 with significant monoallelic
DNAmethylation. Using the rs2244352 SNP, here we demonstrated that the locus undergoes
maternal-of-origin-specific differential methylation. We showed that in hESCs theWRB CGI-
2 is hypermethylated, in contrast to the differential maternally inherited allele methylation pro-
file observed in blood cells. A hypermethylated state for theWRB CGI-2 DMR occurs in several
methylome studies of hESCs [35, 41, 42]. Significantly, we observed a biallelic transcriptional
expression pattern forWRB, despite the hypermethylated state in hESCs.
The hemimethylated status characteristic of the known imprinted DMRs is not a sufficient
epigenetic signature to determine the uniparental monoallelic expression of genes. For exam-
ple, the gDMR in the GRB10 gene, which is isoform-specifically imprinted only in the brain, is
hemimethylated in all tissues analyzed [55, 69]. We observed a comparable confluence of both
the 17-histone modification activation backbone module and the 5-histone modification
repressive module between six maternally imprinted genes (MEST, BLCAP, GNAS, IGF2R,
GRB10, and RB1) and theWRB gene. Therefore, there is still the possibility of theWRB gene
being an isoform- and tissue-specific imprinted gene. Due to the unavailability of isoform-spe-
cific SNPs and the small levels of expression of theWRB transcript variant 2 in RNA-Seq
experiments, unfortunately, we could not test that hypothesis with our current approach.
In a recent methylome study in human oocytes, Okae and collaborators [46] used the crite-
ria of DNAmethylation levels at the DMRs of known imprinted genes to classify theWRB
CGI-2 as a secondary DMR (i.e., rather than a gDMR). At theWRB CGI-2, they observed an
average methylation of 17.5% in oocytes (hg19 coordinates chr21:40757510–40758276; 11.5%
in oocytes pool 1 PCR and 49.9% in oocyte pool 2) and of 0.45% in sperm, but with 35–65%
methylation levels in blood cells. Importantly, a genome-wide scan of the methylomes of
oocytes and blastocysts from that study revealed that the methylation profiles are highly com-
parable, with the methylation levels of maternal germline DMRs in blastocysts being on aver-
age half the levels found in oocytes (data not shown). Because the reported level of methylation
at theWRB CGI-2 in blastocyst was 37.72% [46], one would expect a methylation level of
approximately 75% in oocytes. In fact, the average methylation level at a core region with hg19
coordinates chr21: 40757603–40757721 in oocyte pool 2 is 70.3% (reanalysis of data from S1
Table of ref. [46]). Therefore, we consider theWRB CGI-2 to be a maternal gDMR.
We demonstrated the maintenance of the DNA sequence context of the humanWRB CGI-
2 DMR in primates. Within theWRB CGI-2 DMR, we identified a cisDNAmotif array. In pri-
mates, the array consists of 2 to 8 consensus repeat units in primates that bear sequence simi-
larity to the DNA-binding specificity consensus site of the transcription factor SPDEF. We
speculate that the cisDNAmotif array is a distinctive feature in the establishment and/or main-
tenance of the hemimethylated state of this particular DMR, rather than being involved in the
differential expression ofWRB transcript variants or alleles.
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WRB is essentially a housekeeping gene. The humanWRB protein corresponds to the Get1
protein in yeast. The WRB/Get1 proteins form a conserved family (IPR028945) in eukaryotes.
These proteins function as transmembrane receptors for ASNA1/TRC40 (Get3 in yeast)-medi-
ated insertion of tail-anchored (TA) proteins into the endoplasmic reticulum membrane
(GO:0071816) [70]. RNA-Seq profiling revealed thatWRB transcription occurs in all individ-
ual tissue categories investigated, although higher levels (i.e., FPKM/TPM) are displayed in the
brain, testis, ovary and kidney [71]. Most tissues displayed moderate to strong nuclear and
cytoplasmic positivity by WRB-specific antibody staining [72]. RNAi-mediated knockdown of
WRB expression increases the rate of homologous recombination DNA double-strand break
repair [73]. Importantly,WRB transcription levels are compensated in trisomic T21 lympho-
blastoid cells [74], and theWRB gene lies outside a chromosomal domain dysregulated by the
presence of the supernumerary chromosome 21 [20]. Therefore, the biological significance of
theWRB gene perhaps being imprinted in an isoform, tissue and/or developmental-stage-spe-
cific manner is rather intriguing.
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